TY - JOUR
T1 - MRI features associated with rapid disease activity in clinically isolated syndrome patients at high risk for multiple sclerosis
AU - De Lury, Amy
AU - Bisulca, Joseph
AU - Coyle, Patricia K.
AU - Peyster, Robert
AU - Bangiyev, Lev
AU - Duong, Tim Q.
N1 - Funding Information:
Stony Brook School of Medicine (TRO-FUSION) pilot grant. We would like to acknowledge the use of the resources of the Biomedical Imaging Research Center (Radiology, Stony Brook Medicine).
Funding Information:
Dr. Patricia K. Coyle has received consulting fees from Accordant, Alexion, Bayer, Biogen Idec, Genentech/Roche, Genzyme/Sanofi, GlaxoSmithKline, Mylan, Novartis, Serono, and TG Therapeutics; research grants from Actelion, Alkermes, Corrona LLD, Genentech/Roche, MedDay, NINDS, Novartis, and PCORI.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/6
Y1 - 2020/6
N2 - Clinically isolated syndrome (CIS) is a central nervous system inflammatory and demyelinating event that lasts at least 24 h and can represent the first episode of relapsing-remitting multiple sclerosis. MRI is an important imaging tool in the diagnosis and longitudinal monitoring of CIS progression. Accurate differential diagnosis of high-risk versus low-risk CIS is important because high-risk CIS patients could be treated early. Although a few studies have previously characterized CIS and explored possible imaging predictors of CIS conversion to MS, it remains unclear which amongst the commonly measured MRI features, if any, are good predictors of rapid disease progression in CIS patients. The goal of this review paper is to identify MRI features in high-risk CIS patients that are associated with rapid disease activity within 5 years as measured by clinical disability.
AB - Clinically isolated syndrome (CIS) is a central nervous system inflammatory and demyelinating event that lasts at least 24 h and can represent the first episode of relapsing-remitting multiple sclerosis. MRI is an important imaging tool in the diagnosis and longitudinal monitoring of CIS progression. Accurate differential diagnosis of high-risk versus low-risk CIS is important because high-risk CIS patients could be treated early. Although a few studies have previously characterized CIS and explored possible imaging predictors of CIS conversion to MS, it remains unclear which amongst the commonly measured MRI features, if any, are good predictors of rapid disease progression in CIS patients. The goal of this review paper is to identify MRI features in high-risk CIS patients that are associated with rapid disease activity within 5 years as measured by clinical disability.
KW - Clinically isolated syndrome
KW - Expanded disability status scale
KW - Magnetic resonance imaging
KW - Neurodegenerative disease
KW - White matter disease
UR - http://www.scopus.com/inward/record.url?scp=85079529878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079529878&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2020.101985
DO - 10.1016/j.msard.2020.101985
M3 - Review article
C2 - 32087591
AN - SCOPUS:85079529878
SN - 2211-0348
VL - 41
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
M1 - 101985
ER -